PET/CT Staging and IMRT Improve Treatment for Pharyngeal Cancer
Author Information
Author(s): Sacha Rothschild, Gabriela Studer, Burkhardt Seifert, Pia Huguenin, Christoph Glanzmann, J Bernard Davis, Urs M Lütolf, Thomas F Hany, I Frank Ciernik
Primary Institution: University of Zurich
Hypothesis
Does the combination of PET/CT and IMRT improve treatment outcomes for advanced pharyngeal carcinoma?
Conclusion
The combination of PET/CT and IMRT significantly improves the treatment outcomes for patients with pharyngeal carcinoma.
Supporting Evidence
- Overall survival at 1 and 2 years was 97% and 91% for the PET/CT-IMRT group compared to 74% and 54% for controls.
- Event-free survival rates were 90% and 80% at 1 and 2 years for the PET/CT-IMRT group versus 72% and 56% for controls.
- Patients treated with PET/CT and IMRT had significantly better locoregional control rates.
Takeaway
Using special imaging and advanced radiation therapy helps people with throat cancer get better treatment and live longer.
Methodology
A matched-pair analysis comparing 45 patients treated with PET/CT and IMRT to 86 controls treated without these technologies.
Potential Biases
Potential selection bias due to matching controls based on historical data.
Limitations
The study is retrospective and may have treatment bias; the impact of each technology could not be isolated.
Participant Demographics
Patients were predominantly male (80%) with a median age of 56 years.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website